Determination of protein-unbound, active rifampicin in serum by ultrafiltration and Ultra Performance Liquid Chromatography with UV detection. A method suitable for standard and hi... von van Ewijk-Beneken Kolmer, Eleonora W.J., Teulen, Marga J.A., van den Hombergh, Erik C.A., van Erp, Nielka E., te Brake, Lindsey H.M., Aarnoutse, Rob E.

Volltext

Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study von Benoist, Guillemette E, van Oort, Inge M, Boerrigter, Emmy, Verhaegh, Gerald W, van Hooij, Onno, Groen, Levi, Smit, Frank, de Mol, Pieter, Hamberg, Paul, Dezentjé, Vincent O, Mehra, Niven, Gerritsen, Winald, Somford, Diederik M, van Erp, Nielka P H, Schalken, Jack A

Volltext

Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost‐effectiveness study von Zuidema, Sander, Desar, Ingrid M.E., Erp, Nielka P., Kievit, Wietske

Volltext

Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abirater... von Boerrigter, Emmy, Benoist, Guillemette E., Oort, Inge M., Verhaegh, Gerald W., Hooij, Onno, Groen, Levi, Smit, Frank, Oving, Irma M., Mol, Pieter, Smilde, Tineke J., Somford, Diederik M., Mehra, Niven, Schalken, Jack A., Erp, Nielka P.

Volltext

Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib von Lankheet, Nienke A. G., Desar, Ingrid M. E., Mulder, Sasja F., Burger, David M., Kweekel, Dinemarie M., Herpen, Carla M. L., Graaf, Winette T. A., Erp, Nielka P.

Volltext

Effect of Aprepitant on Etoposide Pharmacokinetics in Patients with Testicular Cancer: A Pharmacokinetic Study to Determine the Absence of a Clinically Relevant Interaction von Strik, Jeffrey, Jong, Loek A. W., Sijm, Joost, Desar, Ingrid M. E., Erp, Nielka P.

Volltext

Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer von Krens, Stefanie D, van Erp, Nielka P, Groenland, Stefanie L, Moes, Dirk Jan A R, Mulder, Sasja F, Desar, Ingrid M E, van der Hulle, Tom, Steeghs, Neeltje, van Herpen, Carla M L

Volltext

The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer von Boerrigter, Emmy, Benoist, Guillemette E., Overbeek, Joanneke K., Donders, Rogier, Mehra, Niven, Oort, Inge M., Heine, Rob, Erp, Nielka P.

Volltext

The impact of patient characteristics on enzalutamide pharmacokinetics and how this relates to treatment toxicity and efficacy in metastatic prostate cancer patients von Benoist, Guillemette E., van Oort, Inge M., Burger, David M., Mehra, Niven, van Erp, Nielka P.

Volltext

Everolimus in patients with advanced follicular-derived thyroid cancer; results of a phase II clinical trial von Schneider, T.C, de Wit, D, Links, T.P, van Erp, N.P, van der Hoeven, J.J.M, Gelderblom, H, Roozen, C.F.M, Bos, M, Corver, W.E, van Wezel, T, Smit, J.W.A, Morreau, H, Guchelaar, H.J, Kapiteijn, E

Volltext

Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update von Giraud, Eline L, de Lijster, Bas, Krens, Stefanie D, Desar, Ingrid M E, Boerrigter, Emmy, van Erp, Nielka P

Volltext

Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators von Westerdijk, Kim, Steeghs, Neeltje, Tacke, Casper S. J., Graaf, Winette T. A., Erp, Nielka P., Oortmerssen, Gerard, Hermens, Rosella P. M. G., Desar, Ingrid M. E.

Volltext

Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide von Benoist, Guillemette E., Hendriks, Rianne J., Mulders, Peter F. A., Gerritsen, Winald R., Somford, Diederik M., Schalken, Jack A., van Oort, Inge M., Burger, David M., van Erp, Nielka P.

Volltext

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer von Fonseca, Nicolette M., Maurice-Dror, Corinne, Herberts, Cameron, Tu, Wilson, Fan, William, Murtha, Andrew J., Kollmannsberger, Catarina, Kwan, Edmond M., Parekh, Karan, Schönlau, Elena, Bernales, Cecily Q., Donnellan, Gráinne, Ng, Sarah W. S., Sumiyoshi, Takayuki, Vergidis, Joanna, Noonan, Krista, Finch, Daygen L., Zulfiqar, Muhammad, Miller, Stacy, Parimi, Sunil, Lavoie, Jean-Michel, Hardy, Edward, Soleimani, Maryam, Nappi, Lucia, Eigl, Bernhard J., Kollmannsberger, Christian, Taavitsainen, Sinja, Nykter, Matti, Tolmeijer, Sofie H., Boerrigter, Emmy, Mehra, Niven, van Erp, Nielka P., De Laere, Bram, Lindberg, Johan, Grönberg, Henrik, Khalaf, Daniel J., Annala, Matti, Chi, Kim N., Wyatt, Alexander W.

Volltext

Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors von Willemsen, Annelieke E.C.A.B., Lubberman, Floor J.E., Tol, Jolien, Gerritsen, Winald R., van Herpen, Carla M.L., van Erp, Nielka P.

Volltext

Analytical challenges in quantifying abiraterone with LC–MS/MS in human plasma von Benoist, Guillemette E., Meulen, Eric, Lubberman, Floor J.E., Gerritsen, Winald R., Smilde, Tineke J., Schalken, Jack A., Beumer, Jan H., Burger, David M., Erp, Nielka P.

Volltext

The Combination of Enzalutamide and Opioids: A Painful Pitfall? von Benoist, Guillemette E., van Oort, Inge M., Burger, David M., Koch, Birgit C.P., Mehra, Niven, van Erp, Nielka P.

Volltext

High-dose administration of tyrosine kinase inhibitors to improve clinical benefit: A systematic review von Gerritse, Sophie L., Janssen, Jorien B.E., Labots, Mariette, de Vries, Ralph, Rudek, Michelle, Carducci, Michael, van Erp, Nielka P., Verheul, Henk M.W.

Volltext

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics von Lubberman, Floor J. E., Benoist, Guillemette E., Gerritsen, Winald, Burger, David M., Mehra, Niven, Hamberg, Paul, van Oort, Inge, van Erp, Nielka P.

Volltext

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal von Lubberman, Floor J E, van Erp, Nielka P, Ter Heine, Rob, van Herpen, Carla M L

Volltext